Genprex, Inc. — Director's Dealing 2021

Jun 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Genprex, Inc. (GNPX)
CIK: 0001595248
Period of Report: 2021-06-24

Reporting Person: Wilson William R Jr. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-24	Stock Option (right to buy)	$3.55	A	32376	Acquired	2031-06-24	Common Stock (32376)	Direct

Footnotes

F1: Equal to the fair market value of a share of common stock on June 24, 2021, the date on which the option grant was made under the Genprex, Inc. Outside Director Compensation Policy.

F2: One hundred percent (100%) of the Shares subject to the Option shall vest upon the earlier of (a) the one (1) year anniversary of June 24, 2021 and (b) the day prior to the Company's next annual meeting of the Company's stockholders occurring after the grant date, provided that the Optionee continues to serve as a Service Provider (as defined in the Genprex, Inc. 2018 Equity Incentive Plan) through the applicable vesting date.